my.naviGATE: A Guide to After-Treatment Effects for Adolescents and Young Adults
- Status
- NOT_YET_RECRUITING
- Phase
- NA
Clinical Trials Related to Acute Myeloid Leukemia
Related studies linked through entity extraction aliases.
Axatilimab Combined With Decitabine/Venetoclax for the Treatment of TP53-mutated AML
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE1
A Study to Find the Highest Dose of SNDX-5613 (Revumenib) as a Treatment Option After Hematopoietic Stem Cell Transplant in Children With Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia, and Mixed Phenotype Acute Leukemia
- Status
- WITHDRAWN
- Phase
- PHASE1
MT2025-35 Allogeneic Hematopoietic Stem Cell Transplantation Using Reduced Intensity Conditioning Treosulfan and Fludarabine, With Post-Transplant Cytoxan (PTCy) for the Treatment of Hematological Diseases
- Status
- RECRUITING
- Phase
- PHASE2
HEM-SURVIVE: Structuralized Follow-up for Childhood Hematological Malignancy Survivors
- Status
- NOT_YET_RECRUITING
- Phase
- N/A
Study Evaluating the Efficacy and Safety of the Addition of Ivosidenib to Oral Azacitidine (Onureg®) in Patients Over 55 With Acute Myeloid Leukemia (AML) and IDH1 Mutation, in Complete Remission After Intensive Chemotherapy.
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE2
IFN-α in Relapse Prevention.
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE2
Assessing PI3K Gamma Inhibition With Azacitidine, Venetoclax and Eganelisib in Patients With Acute Myeloid Leukemia
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE1
Comparing Different Treatment Lengths for Venetoclax in Older People With Newly Diagnosed Acute Myeloid Leukemia (A MyeloMATCH Treatment Trial)
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE2
Selinexor Combined With Induction Chemotherapy for Children With NUP98-positive AML
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
Clinical Study on the Safety, Efficacy and Pharmacokinetics of Universal CLL1 Chimeric Antigen Receptor T-Cell in Relapsed/Refractory Acute Myeloid Leukemia
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE1
Venetoclax Combined With Azacitidine for Consolidation Therapy in AML
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE2
Design and Validation of a Generative AI and Propensity Score Matching Model for the VEN-DEC Phase II Study in Elderly AML Eligible for Allo-SCT; Evaluation of an Exploratory Approach Respect to a Randomized Phase III Trial
- Status
- RECRUITING
- Phase
- N/A
Phase 1/1b Trial Of Olutasidenib And Ziftomenib For NPM1 And IDH1 Co-Mutated Acute Myeloid Leukemia
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE1
Shortened Venetoclax Duration Based on Day 14 BM Blasts Versus Standard Therapy in Elderly or Frail Patients With AML Patients Treated With Azacitidine Plus Venetoclax
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE3
Motixafortide for MRD Sensitization in AML
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE2
A Study of the Combination of Ivosidenib, Azacitidine, and Venetoclax Followed by Ivosidenib Alone in People With Acute Myeloid Leukemia
- Status
- RECRUITING
- Phase
- PHASE2
Effect of Hypnosis and Virtual Reality on Anxiety During Treatment for Acute Myeloid Leukemia
- Status
- NOT_YET_RECRUITING
- Phase
- NA
First-in-human (FIH) Trial of GEN3018 in Relapsed or Refractory (R/R) Acute Myeloid Leukemia (AML) or Higher-risk Myelodysplastic Syndrome (HR-MDS)
- Status
- RECRUITING
- Phase
- PHASE1
Adoptive T Cell Therapy With DC/AML Fusion Vaccine Plus Decitabine and Venetoclax in AML
- Status
- RECRUITING
- Phase
- PHASE1